Pampa Metals Reports Drilling Results from its Redondo-Veronica Project in Chile With Indications of Deep Porphyry Systems
VANCOUVER, BC / ACCESSWIRE / September 28, 2021 / Pampa Metals Corp. (“Pampa Metals” or…
VANCOUVER, BC / ACCESSWIRE / September 28, 2021 / Pampa Metals Corp. (“Pampa Metals” or…
VANCOUVER, BC / ACCESSWIRE / September 28, 2021 / Commerce Resources Corp. (TSXV:CCE)(FSE:D7H0)(OTCWX:CMRZF) (the “Company”…
VANCOUVER, BC / ACCESSWIRE / September 28, 2021 / ZincX Resources Corp. (“ZincX Resources” or…
VANCOUVER, BC / ACCESSWIRE / September 28, 2021 / Cielo WasteSolutions Corp. (TSXV:CMC)(OTCQB:CWSFF) (“Cielo” or…
Montara H6 well successfully brought onstream SINGAPORE, SINGAPORE / ACCESSWIRE / September 28, 2021 /…
WOKINGHAM, UK / ACCESSWIRE / September 28, 2021 / Ferguson plc (LSE:FERG)(NYSE:FERG) Results for the…
GENEVA, SWITZERLAND / ACCESSWIRE / September 28, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) (“Relief“),…
Product roll out and pilot studies planned for the fourth quarter 2021 TORONTO, ON /…
PORT ST. LUCIE, FL / ACCESSWIRE / September 27, 2021 / With the worldwide landscape…
VANCOUVER, BC / ACCESSWIRE / September 27, 2021 / CoTec Holdings Corp. (TSXV:CTH.H) (“CoTec“ or…
The Intuitive Platform Offers Detailed Reviews of Professional Movers from Around the United States NEW…
Enabling resellers to take advantage of SASE growth opportunities Reading, UK – 28th September 2021…
CloudCasa introduces disruptive pricing model and continues its industry leading free service tier for Kubernetes…
Study compares security measures publicly declared by organisations with evidence-based assessments through the CyberVadis platform…
New quarterly report reveals most in-demand goods bought for resale using automated bots Manchester, UK…
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq:…
Polθ inhibitor, ART4215, is the first selective, orally bioavailable, small molecule inhibitor of the Polθ…
GHENT, Belgium, Sept. 28, 2021 (GLOBE NEWSWIRE) — MRM Health, a biopharmaceutical company developing next-generation…
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate High…
REGULATED INFORMATION Bone Therapeutics will gain access to iPS cell lines, including hypoimmunogenic cell lines,…